References
- Kay L, Jørgensen T. Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 1994;29:1–6.
- Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992;102:1259–68.
- Jones RH, Lydeard SE, Hobbs FDR, Kenkre JE, Williams EI, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990;31:401–5.
- Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989;39:495–8.
- Meineche-Schmidt V, Krag E. Dyspepsia in general practice in Denmark. A one year analysis of consulters in general practice. Scand J Prim Health Care 1998;16:216–21.
- Morell DC, Gage HG, Robinson NA. Symptoms in general practice. J R Coll Gen Pract 1971;21:32–43.
- Warndorff DK, Knottnerus JA, Huijnen LGJ, Starmans R. How well do general practitioners manage dyspepsia? J R Coll Gen Pract 1989;39:499–502.
- Heikkinen M, Pikkarainen P, Takala J, Rasanen H, Jelkunen R. Etiology of dyspepsia: four hundred unselected consecutive patients in general practice. Scand J Gastroenterol 1995;30:519–23.
- Nyrén O, Adami H-O, Gustavsson S, Lööf L. Excess sick-listing in nonulcer dyspepsia. J Clin Gastroenterol 1986;8:339–45.
- Talley NJ, Meineche-Schmidt V, Paré P, Duckworth M, Räisäinen P, Pap A, et al. Efficacy of omeprazole in functional dyspepsia: double-blind randomized placebo-controlled trials. Aliment Pharmacol Ther 1998;12:1055–65.
- Talley NJ. Drug treatment of functional dyspepsia. Scand J Gastroenterol 1991;26 Suppl 182:47–60.
- Veldhuyzen van Zanten SJO, Cleary C, Talley NJ, Peterson TC, Nyren O, Bradley LA, et al. Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for the design of future trials. Report of an international working party. Am J Gastroenterol 1996;91:660–73.
- Svedlund J, Sjödin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988;33:129–34.
- Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux. Qual Life Res 1998;7: 75–83.
- Dimenäs E, Glise H, Hallerback B, Henquist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995;30:1046–52.
- Wiklund I, Bardhan KD, Muller-Lisner S, Bigard MA, Bianchi-Porro G, Ponce J, et al. Quality of life during acute and intermittent treatment of gastroesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre study. Ital J Gastroenterol Hepatol 1998;30:19–27.
- Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994;343:811–6.
- Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995;7: 829–33.
- Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol 1996;31 Suppl 221:8–13.
- Blum AL, Arnold R, Koelz HR, Stolte M. Treatment of functional dyspepsia with omeprazole and ranitidine [abstract]. Gastroenterology 1997;A97:856.
- Meineche-Schmidt V, Krag E. Antisecretory therapy in 1017 patients with ulcer-like or reflux-like dyspepsia in general practice. Eur J Gen Pract 1997;3: 125–30.